Tag: health news latest
Health Care Select Sector SPDR Fund (NYSEARCA:XLV – Get Rating) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $131.02 and traded as low as $124.97. Health Care Select Sector
A majority of people living with Alzheimer’s disease are women, and in the wake of the starting stat, some Canadians are hoping to help mitigate their chances with an app that helps promote healthy brain habits.
Kathy Kelaidis, a busy
Asa neurosurgeon, Henry Marsh has spent several decades making people’s brains better (and occasionally, as his memoirs document with breathtaking honesty, making them worse). But that job involved removing tumors and patching up the aftermath of serious head traumas.
The Surrey Board of Trade (SBoT) is calling on the provincial government to step up funding for healthcare in what will soon be British Columbia’s largest city.
The organization released a report Thursday warning that health-care facilities for the province’s
The Ohio Department of Health will set up a clinic in East Palestine with help from federal officials to address the medical needs of residents, Gov. Mike DeWine announced Friday.
The governor spoke with the White House this week and
Manitoba’s Opposition NDP is calling on the governing Tories to spend more money on the public health-care system so private agencies are not necessary to fill the province’s health-care gaps.
On Friday, health critic Uzoma Asagwara released data from a
Phoenix-based Banner Health has paid $1.25 million to settle a federal probe into a massive 2016 data breach from a hacking incident that disclosed the protected health information of roughly 2.8 million consumers.
Investigators found evidence of “long term, pervasive
The report, released Tuesday, also says that compared with peer nations, the US has the highest rates of death from avoidable or treatable causes and the highest maternal and infant death rates.
The United States spends more on health care
A new made-in-Canada COVID-19 vaccine that can be inhaled is set to enter Phase 2 human trials.
The vaccine is being developed at McMaster University in Hamilton, Ont.
“There is a pressing need to develop new, more effective next-generation vaccine